Pancreas transplantation: Lessons learned from a decade of experience at wake forest Baptist medical center

Review of Diabetic Studies

Volumn 8, Issue 1, 2011, Pages 17-27

  Rogers, Jeffrey ^a   Farney, Alan C ^a   Al Geizawi, Samer ^a   Iskandar, Samy S ^a   Doares, William ^a   Gautreaux, Michael D ^a   Hart, Lois ^a   Kaczmorski, Scott ^a   Reeves Daniel, Amber ^a   Winfrey, Stephanie ^a   Ghanta, Mythili ^a   Adams, Patricia L ^a   Stratta, Robert J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Alemtuzumab; Mycophenolate mofetil pancreas transplantation; Portal enteric; Rabbit anti thymocyte globulin; Simultaneous kidney pancreas transplantation; Tacrolimus; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; CEFAZOLIN; COTRIMOXAZOLE; DEXAMETHASONE; FLUCONAZOLE; HEPARIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; WARFARIN; C PEPTIDE;

DIABETIC PATIENT; DRUG DOSE INCREASE; DRUG ELIMINATION; GRAFT FAILURE; GRAFT INFECTION; GRAFT SURVIVAL; HEART DEATH; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; METHODOLOGY; PANCREAS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

C-PEPTIDE; DIABETES MELLITUS, TYPE 2; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; PANCREAS; PANCREAS TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80055074989     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2011.8.17     Document Type: Review

References (26)

1. Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg 2008. 206(5):1028-1037.
2. Farney AC, Hines MH, Al-Geizawi S, Rogers J, Stratta RJ. Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants. J Am Coll Surg 2011. 212(4):440-451.
3. Stratta RJ, Sundberg AK, Farney AC, Rohr MS, Hartmann EL, Adams PL. Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage. Transplant Proc 2005. 37(8):3546-3548.
4. Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation 2009. 88(6):810-819.
5. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008. 8(4):753-760.
6. Papadimitriou JC, Drachenberg CB, Wiland A, Klassen DK, Fink J, Weir MR, Cangro C, Schweitzer EJ, Bartlett ST. Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatment. Transplantation 1998. 66(12):1741-1745.
7. Drachenberg CB, Odorico J, Demetris AJ, Arend L, Bajema IM, Bruijn JA, Cantarovich D, Cathro HP, Chapman J, Dimosthenous K, et al. Banff schema for grading pancreas allograft rejection. Working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008. 8(6):1237-1249.
8. Orlando G, Stratta RJ and Light J. Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant 2011. 16(1):110-115.
9. Singh RP, Rogers J, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ. Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation? Transplant Proc 2008. 40(2):510-512.
10. Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc 2008. 40(2):502-505.
11. Gruessner AC, Sutherland DE and Gruessner RW. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 2010. 15(1):93-101.
12. Gruessner AC and Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005. 19(4):433-455.
13. Stratta RJ, Taylor RJ, Grune MT, Sindhi R, Sudan D, Castaldo P, Cushing KA, Radio SJ, Wisecarver JL, Matamoros A, et al. Experience with protocol biopsies after solitary pancreas transplantation. Transplantation 1995. 60(12):1431-1437.
14. Stratta RJ, Farney AC and Rogers J. Import pancreas allografts: good from far or far from good? Transplantation 2009. 88(5):622-623.
15. Wiseman AC, Wainright JL, Sleeman E, McBride MA, Baker T, Samana C and Stock P. An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation 2010. 90(5):475-480.
16. Thai N, Khan A, Tom K, Blisard D, Basu A, Tan HP, Marcos A, Fung JJ, Starzl TE, Shapiro R. Alemtuzumab induction and tacrolimus monotherapyin pancreas transplantation. Transplantation 2006. 82(12):1621-1624.
17. Magliocca JF, Odorico JS, Pirsch JD, Becker YT, Knechtle SJ, Leverson GE, Sollinger HW. A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. Am J Transplant 2008. 8(8):1702-1710.
18. Nath DS, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DE, Humar A. Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant 2005. 19(6):792-797.
19. Light JA, Barhyte DY. Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: similar 10-year outcomes. Transplant Proc 2005. 37(2):1283-1284.
20. Fernandez LA, Turgeon NA, Odorico JS, Leverson G, Pirsch JD, Becker BN, Chin LT, Becker YT, Knechtle SJ, Foley DP, et al. Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant 2004. 4(12):2093-2101.
21. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the Unites States, 1996-2005. Am J Transplant 2007. 7(5 Pt 2):1359-1375.
22. Stegall MD, Dean PG, Sung R, Guidinger MK, McBride MA, Sommers C, Basadonna G, Stock P, Leichtman AB. The rationale for the new deceased donor pancreas allocation schema. Transplantation 2007. 83(9):1156-1161.
23. Salvalaggio PR, Davies DB, Fernandez LA, Kaufman DB. Outcomes of pancreas transplantation in the Unite States using cardiac-death donors. Am J Transplant 2006. 6(5 Pt 1):1059-1065.
24. Fernandez LA, DiCarlo A, Odorico JS, Leverson GE, Shames BD, Becker YT, Chin LT, Pirsch JD, Knechtle SJ, Foley DP, et al. Simultaneous pancreaskidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg 2005. 242(5):716-723.
25. Casey ET, Smyrk TC, Burgart LJ, Stegall MD, Larson TS. Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens. Transplantation 2005. 79(12):1717-1722.
26. Humar A, Khwaja K, Ramcharan T, Asolati M, Kandaswamy R, Gruesner RW, Sutherland DE, Gruessner AC. Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation 2003. 76(6):918-923.